ASND
Featured PickAscendis Pharma A/S
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
82
Entry Price
$248.55
Current Price
$75.03
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-13
Executive Summary
Ascendis Pharma (ASND) is staging a powerful momentum breakout to new 52-week highs, fueled by the strategic transition to a direct Nasdaq listing of its ordinary shares. This structural shift, effective April 20, is poised to significantly expand global investor access and facilitate inclusion in major equity indexes, driving fresh institutional accumulation. In our current RISK_ON regime where stable volatility and geopolitical relief reward high-beta momentum, ASND's setup perfectly aligns with aggressive capital deployment.
Technical Context
Setup
The stock is surging at its 52-week high on double its 20-day average volume (2.0x), confirming robust institutional demand and a +10.0% 20-day momentum surge.
Invalidation (Stop)
The bullish thesis is invalidated if ASND breaks below its established support level at $215.54 on elevated volume.
Runner-ups
Recent Performance History
48 Total Picks • 56% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-10 | DBRG | $15.55 | $15.57 | +0.13% | N/A | N/A | N/A |
| 2026-04-09 | PKBK | $29.80 | $29.68 | -0.40% | N/A | N/A | N/A |
| 2026-04-08 | PKBK | $29.15 | $29.68 | +1.82% | N/A | N/A | N/A |
| 2026-04-07 | FOLD | $14.47 | $14.46 | -0.07% | N/A | N/A | N/A |
| 2026-04-06 | ROL | $54.13 | $54.66 | +0.98% | +0.98% | N/A | N/A |
| 2026-04-02 | DAR | $64.65 | $61.41 | -5.01% | -5.12% | N/A | N/A |
| 2026-04-01 | FOLD | $14.44 | $14.46 | +0.14% | +0.14% | N/A | N/A |
| 2026-03-31 | TKO | $201.65 | $195.47 | -3.06% | -2.30% | N/A | N/A |
| 2026-03-30 | TKO | $195.41 | $195.47 | +0.03% | +0.82% | N/A | N/A |
| 2026-03-27 | PRA | $24.58 | $24.59 | +0.04% | -1.55% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0